Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:316523.
doi: 10.1155/2013/316523. Epub 2013 Jul 25.

Oxidative stress and the pathogenesis of Alzheimer's disease

Yan Zhao  1 , Baolu Zhao
Affiliations
Review

Oxidative stress and the pathogenesis of Alzheimer's disease

Yan Zhao et al. Oxid Med Cell Longev. 2013.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly. Patients with AD suffer a gradual deterioration of memory and other cognitive functions, which eventually leads to a complete incapacity and death. A complicated array of molecular events has been implicated in the pathogenesis of AD. The major pathological characteristics of AD brains are the presence of senile plaques, neurofibrillary tangles, and neuronal loss. Growing evidence has demonstrated that oxidative stress is an important factor contributing to the initiation and progression of AD. However, the mechanisms that lead to the disruption of redox balance and the sources of free radicals remain elusive. The excessive reactive oxygen species may be generated from mechanisms such as mitochondria dysfunction and/or aberrant accumulation of transition metals, while the abnormal accumulation of Abeta and tau proteins appears to promote the redox imbalance. The resulted oxidative stress has been implicated in Abeta- or tau-induced neurotoxicity. In addition, evidence has suggested that oxidative stress may augment the production and aggregation of Abeta and facilitate the phosphorylation and polymerization of tau, thus forming a vicious cycle that promotes the initiation and progression of AD.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Querfurth HW, LaFerla FM. Alzheimer’s disease. The New England Journal of Medicine. 2010;362(4):329–344. - PubMed
    1. 2010 Alzheimer’s disease facts and figures. Alzheimer's & Dementia. 2010;6:158–194. - PubMed
    1. Dong M-J, Peng B, Lin X-T, Zhao J, Zhou Y-R, Wang R-H. The prevalence of dementia in the People’s Republic of China: a systematic analysis of 1980–2004 studies. Age and Ageing. 2007;36(6):619–624. - PubMed
    1. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. The Lancet. 2005;366(9503):2112–2117. - PMC - PubMed
    1. Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet Neurology. 2008;7(9):812–826. - PMC - PubMed

Publication types

MeSH terms

Substances